259 related articles for article (PubMed ID: 25784440)
21. Changes in Kidney Function and in the Rate of Tubular Dysfunction After Tenofovir Withdrawal or Continuation in HIV-Infected Patients.
Casado JL; Del Rey JM; Bañón S; Santiuste C; Rodriguez M; Moreno A; Perez-Elías MJ; Liaño F; Moreno S
J Acquir Immune Defic Syndr; 2016 Aug; 72(4):416-22. PubMed ID: 26962850
[TBL] [Abstract][Full Text] [Related]
22. Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity.
Bonjoch A; Echeverría P; Perez-Alvarez N; Puig J; Estany C; Clotet B; Negredo E
Biomed Res Int; 2016; 2016():4380845. PubMed ID: 28078289
[No Abstract] [Full Text] [Related]
23. Renal Toxicity of Concomitant Exposure to Tenofovir and Inhibitors of Tenofovir's Renal Efflux Transporters in Patients Infected With HIV Type 1.
Rokx C; Alshangi H; Verbon A; Zietse R; Hoorn EJ; Rijnders BJ
J Infect Dis; 2016 Feb; 213(4):561-8. PubMed ID: 26401025
[TBL] [Abstract][Full Text] [Related]
24. Tenofovir-associated renal and bone toxicity.
Woodward CL; Hall AM; Williams IG; Madge S; Copas A; Nair D; Edwards SG; Johnson MA; Connolly JO
HIV Med; 2009 Sep; 10(8):482-7. PubMed ID: 19459988
[TBL] [Abstract][Full Text] [Related]
25. Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-infected patients.
Casado JL; Santiuste C; Vazquez M; Bañón S; Rosillo M; Gomez A; Perez-Elías MJ; Caballero C; Rey JM; Moreno S
AIDS; 2016 Jun; 30(9):1423-31. PubMed ID: 26919733
[TBL] [Abstract][Full Text] [Related]
26. A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection.
Likanonsakul S; Suntisuklappon B; Nitiyanontakij R; Prasithsirikul W; Nakayama EE; Shioda T; Sangsajja C
PLoS One; 2016; 11(1):e0147724. PubMed ID: 26807589
[TBL] [Abstract][Full Text] [Related]
27. Renal tubular dysfunction associated with tenofovir therapy.
Mitra S; Priscilla R; Rajeev K; Sauradeep S; Rajkumar S; Cherian AO
J Assoc Physicians India; 2014 Jul; 62(7):580-2. PubMed ID: 25672029
[TBL] [Abstract][Full Text] [Related]
28. Tenofovir disoproxil fumarate-associated renal tubular dysfunction: noninvasive assessment of mitochondrial injury.
Samuels R; Bayerri CR; Sayer JA; Price DA; Payne BAI
AIDS; 2017 Jun; 31(9):1297-1301. PubMed ID: 28323756
[TBL] [Abstract][Full Text] [Related]
29. Temporal changes in renal glomerular function associated with the use of Tenofovir Disoproxil Fumarate in HIV-infected Nigerians.
Agbaji OO; Agaba PA; Idoko JA; Taiwo B; Murphy R; Kanki P; Ekong E
West Afr J Med; 2011; 30(3):164-8. PubMed ID: 22120479
[TBL] [Abstract][Full Text] [Related]
30. Tenofovir exposure alters associations of serum bicarbonate with chronic kidney disease risk in HIV-infected veterans.
Kim JE; Scherzer R; Estrella MM; Ix JH; Shlipak MG
AIDS; 2016 Apr; 30(7):1049-57. PubMed ID: 26760455
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of renal dysfunction among HIV infected patients receiving Tenofovir at Mulago: a cross-sectional study.
Nyende L; Kalyesubula R; Sekasanvu E; Byakika-Kibwika P
BMC Nephrol; 2020 Jun; 21(1):232. PubMed ID: 32571236
[TBL] [Abstract][Full Text] [Related]
32. Mitochondrial dysfunction and electron transport chain complex defect in a rat model of tenofovir disoproxil fumarate nephrotoxicity.
Ramamoorthy H; Abraham P; Isaac B
J Biochem Mol Toxicol; 2014 Jun; 28(6):246-55. PubMed ID: 24615786
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous measurement of urinary albumin and total protein may facilitate decision-making in HIV-infected patients with proteinuria.
Samarawickrama A; Cai M; Smith ER; Nambiar K; Sabin C; Fisher M; Gilleece Y; Holt SG
HIV Med; 2012 Oct; 13(9):526-32. PubMed ID: 22413854
[TBL] [Abstract][Full Text] [Related]
34. Tubular and glomerular proteinuria in HIV-infected adults with estimated glomerular filtration rate ≥ 60 ml/min per 1.73 m2.
Reynes J; Cournil A; Peyriere H; Psomas C; Guiller E; Chatron M; Cristol JP; Badiou S
AIDS; 2013 May; 27(8):1295-302. PubMed ID: 23925378
[TBL] [Abstract][Full Text] [Related]
35. Acute kidney injury caused by tenofovir disoproxil fumarate and diclofenac co-administration.
Bickel M; Khaykin P; Stephan C; Schmidt K; Buettner M; Amann K; Lutz T; Gute P; Haberl A; Geiger H; Brodt HR; Jung O
HIV Med; 2013 Nov; 14(10):633-8. PubMed ID: 23980564
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of Persistent Renal Dysfunction in Perinatally HIV-infected Thai Adolescents.
Bunupuradah T; Phupitakphol T; Sophonphan J; Prasitsuebsai W; Anugulruengkitt S; Jantarabenjakul W; Sopa B; Ruxrungtham K; Chanakul A; Puthanakit T;
Pediatr Infect Dis J; 2018 Jan; 37(1):66-70. PubMed ID: 28719505
[TBL] [Abstract][Full Text] [Related]
37. Renal outcomes in patients initiated on tenofovir disoproxil fumarate-based antiretroviral therapy at a community health centre in Malawi.
Chikwapulo B; Ngwira B; Sagno JB; Evans R
Int J STD AIDS; 2018 Jun; 29(7):650-657. PubMed ID: 29334883
[TBL] [Abstract][Full Text] [Related]
38. Tenofovir disoproxil fumarate initiation and changes in urinary biomarker concentrations among HIV-infected men and women.
Zhang WR; Scherzer R; Estrella MM; Ascher SB; Muiru A; Jotwani V; Grunfeld C; Parikh CR; Gustafson D; Kassaye S; Sharma A; Cohen M; Tien PC; Ng DK; Palella FJ; Witt MD; Ho K; Shlipak MG
AIDS; 2019 Mar; 33(4):723-733. PubMed ID: 30830887
[TBL] [Abstract][Full Text] [Related]
39. Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases.
Cho H; Cho Y; Cho EJ; Lee JH; Yu SJ; Oh KH; Lee K; Mustika S; Yoon JH; Kim YJ
Clin Mol Hepatol; 2016 Jun; 22(2):286-91. PubMed ID: 27377911
[TBL] [Abstract][Full Text] [Related]
40. Early switching of tenofovir disoproxil fumarate (TDF) in HIV-infected patients with TDF-induced nephrotoxicity: a prospective study.
Patamatamkul S; Songumpai N; Payoong P; Katavetin P; Putcharoen O
HIV Res Clin Pract; 2022 Aug; 23(1):99-106. PubMed ID: 36065999
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
